France’s Sanofi to buy U.S. drugs project INBRX-101 for about $2.2 bln – ET HealthWorld | Pharma
Paris: French healthcare company Sanofi has agreed to buy the drug development project INBRX-101 from its parent company Inhibrx Inc…
Sanofi
Continue reading
Blockchain in Pharma Unleashes a New Era of Trust and Efficiency – ET HealthWorld
In the ever-evolving landscape of pharmaceuticals, where precision, safety, and trust are non-negotiable, blockchain technology emerges as the beacon of…
Lupin to acquire established products in Europe, Canada from Sanofi for Rs 91 cr – ET HealthWorld | Pharma
New Delhi: Home-grown pharma major Lupin Ltd on Friday said it acquired a portfolio of established products in Europe and…
Sanofi to focus on 12 blockbuster drug candidates, immunology pipeline – ET HealthWorld | Pharma
New Delhi: Sanofi said on Thursday it will focus on 12 potential blockbuster drug candidates and prioritise development in immunology,…
Government plans to offer support for treatment of rare diseases – ET HealthWorld
The government is likely to soon come up with a mechanism for providing treatment support to patients suffering from rare…
French drugmaker Sanofi considers listing consumer unit late next year – ET HealthWorld | Pharma
New Delhi: Sanofi has mapped out a separate listing of its consumer healthcare business from the fourth quarter of next…
Drugmaker GSK settles California lawsuit on Zantac – ET HealthWorld | Pharma
GSK on Wednesday said it had reached a confidential settlement on a litigation in California alleging that the British drugmaker’s…
More public awareness is required for innovative treatments for difficult-to-treat illnesses like atopic dermatitis: Anil Raina, Sanofi – ET HealthWorld
Shahid Akhter, editor, ETHealthworld, spoke to Anil Raina, General Manager (Speciality Care), Sanofi, to know more about the advancements in…
Amazon Pharmacy automates discounts to help insulin patients get pledged prices – ET HealthWorld
By Patrick Wingrove – Amazon.com said on Tuesday its online pharmacy will automatically apply manufacturer-sponsored coupons to more than 15…
Sanofi receives marketing approval for Dupixent in India – ET HealthWorld | Pharma
Mumbai: Sanofi Healthcare India Pvt. Ltd. on Tuesday announced that they have obtained marketing approval for Dupixent (dupilumab). This marks…